5-Amino-1MQ is currently available in oral form
Tesamorelin FDA-approved for HIV-associated lipodystrophy, its used off-label to reduce abdominal fat and improve metabolic health
Realistic expectations are essentialthis is not a magic bullet for rapid dramatic weight loss
Researched effects In a diet-induced-obese mouse study (Neelakantan et al., Biochemical Pharmacology, 2018), subcutaneous 5-Amino-1MQ (20 mg/kg, three times daily, roughly 11 days) produced about 5.1% body-weight loss versus continued weight gain in untreated controls, roughly 35% less epididymal white fat mass, smaller adipocytes, lower plasma cholesterol, and improved glucose tolerance, with no reported change in food intake and no observed adverse effects in the mice
The outer thigh has fewer nerves and blood vessels, which helps reduce the discomfort associated with the injection